These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 38188746)

  • 1. Retracted: A Molecular Mechanism Study to Reveal Hirudin's Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFR
    International BR
    Biomed Res Int; 2023; 2023():9809487. PubMed ID: 38188746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Molecular Mechanism Study to Reveal Hirudin's Downregulation to PI3K/AKT Signaling Pathway through Decreasing PDGFR
    Li Y; Zhang L; Xiong W; Gao X; Xiong Y; Sun W
    Biomed Res Int; 2022; 2022():5481552. PubMed ID: 36119923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rapid determination of contents of hirudin's hydrolysates in processed leech by dot blotting].
    Wang HW; Tian JZ
    Zhongguo Zhong Yao Za Zhi; 2008 Oct; 33(19):2193-5. PubMed ID: 19166004
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retracted: si-PDGFR
    Longevity OMAC
    Oxid Med Cell Longev; 2024; 2024():9839740. PubMed ID: 38236530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Retracted: Research Progress of PI3K/PTEN/AKT Signaling Pathway Associated with Renal Cell Carcinoma.
    Markers D
    Dis Markers; 2023; 2023():9756735. PubMed ID: 37502574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fufang Shenhua tablet inhibits renal fibrosis by inhibiting PI3K/AKT.
    Li R; Shi C; Wei C; Wang C; Du H; Liu R; Wang X; Hong Q; Chen X
    Phytomedicine; 2023 Jul; 116():154873. PubMed ID: 37257328
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retracted: MicroRNA-517c Functions as a Tumor Suppressor in Hepatocellular Carcinoma via Downregulation of KPNA2 and Inhibition of PI3K/AKT Pathway.
    Engineering JOH
    J Healthc Eng; 2023; 2023():9873529. PubMed ID: 36756140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of the Bupi Yishen formula on renal fibrosis through PI3K/AKT signaling inhibition.
    Liu B; Deng J; Jie X; Lu F; Liu X; Zhang D
    J Ethnopharmacol; 2022 Jul; 293():115242. PubMed ID: 35367329
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retracted: miR-29c Inhibits Renal Interstitial Fibrotic Proliferative Properties through PI3K-AKT Pathway.
    And Biomechanics AB
    Appl Bionics Biomech; 2023; 2023():9764163. PubMed ID: 38152754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PDGF receptor-β uses Akt/mTORC1 signaling node to promote high glucose-induced renal proximal tubular cell collagen I (α2) expression.
    Das F; Ghosh-Choudhury N; Venkatesan B; Kasinath BS; Ghosh Choudhury G
    Am J Physiol Renal Physiol; 2017 Aug; 313(2):F291-F307. PubMed ID: 28424212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retracted: The Mechanism of Xiaoyao San in the Treatment of Ovarian Cancer by Network Pharmacology and the Effect of Stigmasterol on the PI3K/Akt Pathway.
    Markers D
    Dis Markers; 2023; 2023():9791279. PubMed ID: 37476639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retracted: TJZYF Improves Endometrial Receptivity through Regulating VEGF and PI3K/AKT Signaling Pathway.
    International BR
    Biomed Res Int; 2023; 2023():9846512. PubMed ID: 38188825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Retracted: DDTC Suppresses Ovarian Cancer Development via the PI3K/AKT/mTOR Signaling Pathway.
    Markers D
    Dis Markers; 2023; 2023():9810565. PubMed ID: 37502573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Retracted] Rapamycin suppresses the PI3K/AKT/mTOR signaling pathway by targeting SIRT1 in esophageal cancer.
    Liu T; Liang X; Sun Y; Yang S
    Exp Ther Med; 2024 Jan; 27(1):1. PubMed ID: 38125358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retracted: The Use of BT-ESD Technology under General Intravenous Anesthesia in the Treatment of Nonmuscle Invasive Bladder Cancer and the Effect of PI3K/Akt Signaling Pathway on Tumor Recurrence.
    International BR
    Biomed Res Int; 2024; 2024():9815062. PubMed ID: 38230038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retracted: MicroRNA-1179 regulates proliferation and chemosensitivity of human ovarian cancer cells by targeting the PTEN-mediated PI3K/AKT signaling pathway.
    Zhihong Z; Rubin C; Liping L; Anpeng M; Hui G; Yanting W; Zhenxiu S
    Arch Med Sci; 2023; 19(2):557. PubMed ID: 37034514
    [TBL] [Abstract][Full Text] [Related]  

  • 17. microRNA-29b prevents renal fibrosis by attenuating renal tubular epithelial cell-mesenchymal transition through targeting the PI3K/AKT pathway.
    Hu S; Hu H; Wang R; He H; Shui H
    Int Urol Nephrol; 2021 Sep; 53(9):1941-1950. PubMed ID: 33742315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Retracted:
    Longevity OMAC
    Oxid Med Cell Longev; 2023; 2023():9817815. PubMed ID: 37565156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Retracted] MicroRNA‑451a prevents cutaneous squamous cell carcinoma progression via the 3‑phosphoinositide‑dependent protein kinase‑1‑mediated PI3K/AKT signaling pathway.
    Fu J; Zhao J; Zhang H; Fan X; Geng W; Qiao S
    Exp Ther Med; 2024 Jul; 28(1):280. PubMed ID: 38800047
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Retracted: Antitumor and apoptotic effects of 5-methoxypsoralen in U87MG human glioma cells and its effect on cell cycle, autophagy and PI3K/Akt signaling pathway.
    Guo H; He Y; Bu C; Peng Z
    Arch Med Sci; 2023; 19(2):556. PubMed ID: 37034538
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.